MENQUADFI (Sanofi-Aventis Australia Pty Ltd)
Product name
MENQUADFI
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
178 (255 working days)
Active ingredients
Meningococcal polysaccharide Group Y, Meningococcal polysaccharide group A, Meningococcal polysaccharide group C, Meningococcal polysaccharide group W135
Registration type
EOI
Indication
MenQuadfi is indicated for active immunisation of individuals from 6 weeks of age against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, W and Y.
The use of MenQuadfi should be in accordance with official recommendations.